drugset / Trial / NCT00154180

Summary

The study will examine the effects of estrogen and progesterone on the development of atherosclerosis in menopausal women when hormone treatment is initiated within 3 years of the menopausal transition.

Timeline

Start
2005-09
Primary completion
2012-05
Completion
2012-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Conjugated equine estrogens Unknown 0.45 mg Oral
Comparator Estradiol Other / unclassified 50 ug Intravenous
Comparator Micronized progesterone Unknown 200 mg Oral